頭頸部がん陽子線治療におけるロバスト性を向上させるためのマルチ画像最適化を用いたトリガー型計画適応
Nadine Vatterodt1,2, Brian Winey3, Stine S Korreman1,2
1Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Physics and imaging in radiation oncology
|December 24, 2025
まとめ
本研究では、頭頸部がん陽子線治療のためのトリガー型ロバスト適応戦略を導入し、解剖学的変動に適応させることで標的被覆率とOARの温存を改善する。この手法は、他の戦略よりも少ない適応回数で治療のロバスト性を向上させる。
科学分野:
- 医学物理学
- 放射線腫瘍学
- 画像誘導治療
背景:
- 頭頸部(HNC)陽子線治療における解剖学的変動は、標的被覆率およびOAR(リスク臓器)の温存を損なう可能性がある。
- 毎日の解剖学的変化は、治療効果と安全性を維持するために適応戦略を必要とする。
研究 の 目的:
- 頭頸部がん陽子線治療におけるトリガー型ロバスト適応戦略の導入と評価。
- 標的およびOARにおける観察された線量偏差に適応させることで、治療計画のロバスト性を向上させる。
主な方法:
- 陽子線治療を受けた5人の中咽頭がん患者の後ろ向き解析。
- 線量再計算のための毎日のコーンビームCTからの合成CTスキャンの生成。
- 4つの戦略の比較:非適応(NA)、トリガー型適応(TA)、単一(TRA-S)および複数(TRA-M)のトリガー型フラクショニミジ画像を用いたトリガー型ロバスト適応。
主要な成果:
- トリガー型ロバスト適応(TRA-SおよびTRA-M)は、NAおよびTAと比較して、標的被覆率(中央値D98%で最大+0.76 Gy)を改善し、閾値違反を減少させた。
- 好ましくない線量偏差が減少し、OAR線量はNAと比較して同等であった。
- TAはOAR線量において同等であったが、標的被覆率を一貫して改善しなかった。
- 積分線量はTRA戦略で増加したが、TRA-SとTRA-Mの差は最小限であった。
結論:
- トリガー型ロバスト適応は、頭頸部がん陽子線治療における標的被覆率とOARの温存を効果的にバランスさせる。
- この戦略は、TAよりも少ない適応回数で済み、予測画像や追加のCTスキャンへの依存を回避する。
- 臨床現場での解剖学的ロバスト最適化の実装に向けた実行可能なアプローチを提供する。
- 科学分野:医学物理学;放射線腫瘍学;画像誘導治療
さらに関連する動画
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.9K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
3.1K
関連する概念動画
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
